ProQR Therapeutics (PRQR) Change in Taxes (2017 - 2025)
ProQR Therapeutics recorded quarterly Change in Taxes of $43069.6 in Q4 2025, up 311.38% quarter-over-quarter from -$20375.3 in Q2 2025, and up 110.23% year-over-year from $20486.9 in Q4 2024.
ProQR Therapeutics' Change in Taxes history runs 9 years deep, the most recent figure standing at $43069.6 for Q4 2025.
- In Q4 2025, Change in Taxes rose 110.23% year-over-year to $43069.6; the TTM figure through Dec 2025 stood at -$398332.3 (down 90.67% YoY), while the FY2025 annual figure was $22116.8, up 110.51% from the prior year.
- Change in Taxes came in at $43069.6 for Q4 2025 at ProQR Therapeutics, up from -$20375.3 in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $215377.5 in Q2 2024 to a low of -$421026.6 in Q4 2024.
- A 5-year average of -$18361.2 and a median of -$14115.8 in 2022 frame the typical range for Change in Taxes.
- Across the five-year window, Change in Taxes sank 426.79% in 2021 and soared 878.34% in 2022, its largest moves.
- ProQR Therapeutics' Change in Taxes stood at -$25167.4 in 2021, then jumped by 878.34% to $195887.5 in 2022, then slumped by 188.43% to -$173226.3 in 2023, then plunged by 143.05% to -$421026.6 in 2024, then jumped by 110.23% to $43069.6 in 2025.
- According to Business Quant data, Change in Taxes over the past three periods registered $43069.6, -$20375.3, and -$421026.6 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | 43,069.61 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 43,069.61 |
| Dec 31, 2025 | 43,069.61 |
| Jun 30, 2025 | -20,375.27 |
| Jun 30, 2025 | -20,375.27 |
| Dec 31, 2024 | -421,026.59 |
| Dec 31, 2024 | -421,026.59 |
| Jun 30, 2024 | 215,377.52 |
| Jun 30, 2024 | 215,377.52 |
| Mar 31, 2024 | -3,259.09 |
| Mar 31, 2024 | -3,259.09 |
| Dec 31, 2023 | -173,226.33 |
| Dec 31, 2023 | -173,226.33 |
| Sep 30, 2023 | 44,632.21 |
| Sep 30, 2023 | 44,632.21 |
| Jun 30, 2023 | 45,734.82 |
| Jun 30, 2023 | 45,734.82 |
| Dec 31, 2022 | 195,887.49 |
| Dec 31, 2022 | 195,887.49 |
| Sep 30, 2022 | -69,570.93 |
| Sep 30, 2022 | -69,570.93 |
| Jun 30, 2022 | -21,341.13 |
| Jun 30, 2022 | -21,341.13 |
| Mar 31, 2022 | -7,856.36 |
| Mar 31, 2022 | -7,856.36 |
| Dec 31, 2021 | -25,167.36 |
| Dec 31, 2021 | -25,167.36 |
| Sep 30, 2021 | -41,275.06 |
| Sep 30, 2021 | -41,275.06 |
| Jun 30, 2021 | -63,826.39 |
| Jun 30, 2021 | -63,826.39 |
| Mar 31, 2021 | 8,443.65 |
| Mar 31, 2021 | 8,443.65 |
| Dec 31, 2020 | -45,307.01 |
| Dec 31, 2020 | -45,307.01 |
| Sep 30, 2020 | 87,605.79 |
| Sep 30, 2020 | 87,605.79 |
| Jun 30, 2020 | -12,116.06 |
| Jun 30, 2020 | -12,116.06 |
| Dec 31, 2019 | -75,268.36 |
| Dec 31, 2019 | -75,268.36 |
| Jun 30, 2019 | -71,912.90 |
| Jun 30, 2019 | -71,912.90 |
| Dec 31, 2018 | -2,282.79 |
| Dec 31, 2018 | -2,282.79 |
| Sep 30, 2018 | 2,326.26 |
| Sep 30, 2018 | 2,326.26 |
| Jun 30, 2018 | -1,193.44 |
| Jun 30, 2018 | -1,193.44 |
| Sep 30, 2017 | 4,700.25 |
| Sep 30, 2017 | 4,700.25 |
| Mar 31, 2017 | -2,130.81 |
| Mar 31, 2017 | -2,130.81 |